Stay updated on LAP of Mepolizumab for MEA115921 Participants Clinical Trial

Sign up to get notified when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates regarding the Mepolizumab Long-term Access Programme for subjects who participated in study MEA115921, including the inclusion criteria and treatment details for eligible subjects. Notably, the term 'Churg-Strauss Syndrome' has been added, while extensive details about the study's objectives and treatment protocols have been removed.
    Difference
    34%
    Check dated 2025-04-16T02:14:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.14.3 to v2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:45:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:51:53.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:19:13.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:46:33.000Z thumbnail image

Stay in the know with updates to LAP of Mepolizumab for MEA115921 Participants Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAP of Mepolizumab for MEA115921 Participants Clinical Trial page.